Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case

Front Cover
W. W. Norton & Company, 1997 - Law - 268 pages
When the FDA banned silicone gel-filled breast implants in 1992, it was responding to mounting concerns that they caused autoimmune and connective tissue disease. The ban triggered a torrent of litigation, as women by the thousands sued breast-implant manufacturers. Sympathetic juries awarded huge damages, leading to a $4.25 billion class-action settlement that still wasn't large enough to cover all the claims. Shockingly, rigorous scientific studies of breast implants then began to show that there is no significant link between breast implants and disease. Why were the courts and the public so certain that breast implants were dangerous when medical researchers were not? The answer to this question reveals important differences in the way science, the law, and the public regard evidence - and not just in the breast-implant controversy. As our society becomes ever more dependent, at all levels, on science and technology, misconceptions about scientific evidence become an increasing danger to the public good - with consequences that extend far beyond the question of whether silicone gel-filled breast implants are safe.
 

What people are saying - Write a review

SCIENCE ON TRIAL: The Clash of Medical Evidence and the Law in the Breast Implant Case

User Review  - Kirkus

A well-crafted demonstration of how differently the law, the public, and science regard evidence, using the breast implant controversy as a case in point. When the FDA banned silicone-filled breast ... Read full review

Science on trial: the clash of medical evidence and the law in the breast implant case

User Review  - Not Available - Book Verdict

Angell, executive editor of the New England Journal of Medicine, addresses the controversy over silicone breast implants, which were banned and the subject of huge lawsuits despite dubious scientific ... Read full review

Contents

Preface
9
Acknowledgments
15
and Who Has Them
33
Litigation
69
and Where It Comes From
90
All That Free Money
133
Other Ways of Knowing
177
Where We Stand and for How Long
192
Copyright

Other editions - View all

Common terms and phrases

About the author (1997)

Marcia Angell is the executive editor of the New England Journal of Medicine.

Bibliographic information